Group One Trading’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-236
| Closed | -$3.32K | – | 8321 |
|
|
2023
Q4 | $3.17K | Sell |
236
-4,292
| -95% | -$54.2K | ﹤0.01% | 6683 |
|
|
2023
Q3 | $55.8K | Buy |
+4,528
| New | +$54.8K | ﹤0.01% | 4991 |
|
|
2022
Q4 | – | Sell |
-11,930
| Closed | -$98.3K | – | 8553 |
|
|
2022
Q3 | $45K | Sell |
11,930
-3,625
| -23% | -$16.7K | ﹤0.01% | 5497 |
|
|
2022
Q2 | $93K | Buy |
15,555
+4,969
| +47% | +$28K | ﹤0.01% | 5052 |
|
|
2022
Q1 | $67K | Buy |
+10,586
| New | +$59.5K | ﹤0.01% | 5875 |
|
|
2021
Q4 | – | Sell |
-31,535
| Closed | -$152K | – | 9249 |
|
|
2021
Q3 | $152K | Sell |
31,535
-2,958
| -9% | -$15.4K | ﹤0.01% | 5463 |
|
|
2021
Q2 | $220K | Buy |
+34,493
| New | +$228K | ﹤0.01% | 5153 |
|
|
2020
Q1 | – | Sell |
-22,621
| Closed | -$66.2K | – | 6143 |
|
|
2019
Q4 | $71K | Buy |
+22,621
| New | +$90.6K | ﹤0.01% | 3839 |
|
|
2019
Q3 | – | Sell |
-871
| Closed | -$4.35K | – | 5886 |
|
|
2019
Q2 | $4K | Sell |
871
-127
| -13% | -$602 | ﹤0.01% | 4678 |
|
|
2019
Q1 | $5K | Hold |
998
| – | – | ﹤0.01% | 4460 |
|
|
2018
Q4 | $3K | Sell |
998
-6,735
| -87% | -$23.4K | ﹤0.01% | 4627 |
|
|
2018
Q3 | $32K | Sell |
7,733
-21,557
| -74% | -$90.8K | ﹤0.01% | 4214 |
|
|
2018
Q2 | $113K | Buy |
29,290
+28,760
| +5,426% | +$191K | ﹤0.01% | 3481 |
|
|
2018
Q1 | $3K | Buy |
+530
| New | +$4.39K | ﹤0.01% | 4621 |
|
|
2017
Q4 | – | Sell |
-684
| Closed | -$8K | – | 5618 |
|
|
2017
Q3 | $8K | Sell |
684
-9,448
| -93% | -$99.3K | ﹤0.01% | 4376 |
|
|
2017
Q2 | $99K | Sell |
10,132
-3,973
| -28% | -$81.2K | ﹤0.01% | 3115 |
|
|
2017
Q1 | $342K | Buy |
14,105
+6,570
| +87% | +$164K | ﹤0.01% | 2139 |
|
|
2016
Q4 | $242K | Sell |
7,535
-449
| -6% | -$19.1K | ﹤0.01% | 2296 |
|
|
2016
Q3 | $399K | Buy |
7,984
+5,768
| +260% | +$239K | ﹤0.01% | 1979 |
|
|
2016
Q2 | $94K | Buy |
+2,216
| New | +$121K | ﹤0.01% | 2910 |
|
|
2015
Q4 | – | Sell |
-13,516
| Closed | -$951K | – | 5415 |
|
|
2015
Q3 | $905K | Buy |
13,516
+11,787
| +682% | +$962K | 0.01% | 1319 |
|
|
2015
Q2 | $168K | Buy |
+1,729
| New | +$165K | ﹤0.01% | 2664 |
|
|
2014
Q3 | – | Sell |
-1,757
| Closed | -$93.9K | – | 5673 |
|
|
2014
Q2 | $101K | Sell |
1,757
-28,552
| -94% | -$1.45M | ﹤0.01% | 2980 |
|
|
2014
Q1 | $1.2M | Buy |
30,309
+27,360
| +928% | +$1.17M | 0.02% | 951 |
|
|
2013
Q4 | $124K | Sell |
2,949
-733
| -20% | -$21.3K | ﹤0.01% | 2847 |
|
|
2013
Q3 | $110K | Buy |
+3,682
| New | +$129K | ﹤0.01% | 2935 |
|
Other funds holding MACK
RA
JC
Group One Trading's MACK Position: Q1 2024 in Review
Group One Trading sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2024, closing a stake of 236 shares — an estimated $3.32K sold.
Group One Trading first reported a position in MACK in Q3 2013 and held it in 26 quarters. The position peaked at $1.2M in Q1 2014. 70 funds tracked by Wall St. Rank hold MACK as of Q1 2024.
- Group One Trading reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 236 Merrimack Pharmaceuticals, Inc. shares in Q1 2024, an estimated $3.32K.
- Group One Trading first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2013 and held it in 26 quarters.
- Group One Trading's Merrimack Pharmaceuticals, Inc. position peaked at $1.2M in Q1 2014.
- 70 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.